A carregar...

EGFR-Targeted Gelatin Nanoparticles for Systemic Administration of Gemcitabine in an Orthotopic Pancreatic Cancer Model

In this study, we have formulated redox-responsive epidermal growth factor receptor (EGFR)-targeted type B gelatin nanoparticles as a targeted vector for systemic delivery of gemcitabine therapy in pancreatic cancer. The gelatin nanoparticles were formed by ethanol-induced desolvation process to enc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nanomedicine
Main Authors: Singh, Amit, Xu, Jing, Mattheolabakis, George, Amiji, Mansoor
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4809767/
https://ncbi.nlm.nih.gov/pubmed/26656632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2015.11.010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!